These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7854995)

  • 21. How to stop the allergy march.
    Lopes Dos Santos JM
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rush desensitization to respiratory allergens].
    Bousquet J; Guèrin B; Michel FB
    Presse Med; 1984 Dec; 13(44):2679-83. PubMed ID: 6240031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous adverse drug reactions seen at a university hospital department of dermatology.
    Borch JE; Andersen KE; Bindslev-Jensen C
    Acta Derm Venereol; 2006; 86(6):523-7. PubMed ID: 17106600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe adverse reactions during specific subcutaneous immunotherapy.
    Ricciardi L; Isola S; Gangemi S; Cilia M; Levanti C; D'Ambrosio FP
    Allergy; 1996 Jan; 51(1):62. PubMed ID: 8721532
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hyposensitizing therapy in an atopic form of bronchial asthma].
    Matkova KP; Silkina AG; Belous VM
    Vrach Delo; 1977 Sep; (9):60-1. PubMed ID: 919485
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse food reactions in patients with grass pollen allergic respiratory disease.
    Boccafogli A; Vicentini L; Camerani A; Cogliati P; D'Ambrosi A; Scolozzi R
    Ann Allergy; 1994 Oct; 73(4):301-8. PubMed ID: 7943997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaphylactic reactions during immunotherapy.
    Rezvani M; Bernstein DI
    Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parameters of immunotherapy: a retrospective study.
    Malet A; Lluch M; Valero A; Amat P
    Allergol Immunopathol (Madr); 1993; 21(1):7-10. PubMed ID: 8328357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment.
    Bruno G; Andreozzi P; Bracchitta S; Graf U; Santangelo G; Zaino S; Gaston N
    Clin Ter; 2001; 152(5):299-303. PubMed ID: 11794849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cetirizine and respiratory tract infections in opinion of Polish doctors].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2006 Nov; 21(125):454-8. PubMed ID: 17345839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of specific immunotherapy to mosquito bites.
    Ariano R; Panzani RC
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Specific immunotherapy--past--present--future].
    Kägi MK
    Praxis (Bern 1994); 1998 Sep; 87(40):1330-4. PubMed ID: 9816927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens.
    Ariano R; Panzani RC; Augeri G
    Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Specific desensitizing therapy in the treatment of respiratory allergic diseases].
    Noferi A; Ferrante E; Testa A
    Folia Allergol (Roma); 1966; 13(4):280-9. PubMed ID: 5990235
    [No Abstract]   [Full Text] [Related]  

  • 35. [Specific and nonspecific hyposensitization of animals with experimental allergy to the antigen from Dermatophagoides pteronyssinus mites].
    Ivanov LN
    Patol Fiziol Eksp Ter; 1979; (1):44-8. PubMed ID: 424244
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term tolerance of specific hyposensitization with the aid of calcium phosphate-adsorbed mite extracts].
    Lelong M; Miersman R
    Allerg Immunol (Paris); 1986 Nov; 18(9):15-6, 18. PubMed ID: 2456078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risks of specific hyposensitization treatment].
    Rakoski J
    Z Hautkr; 1988; 63 Suppl 4():26-30. PubMed ID: 3075381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of adverse effects during specific hyposensitization therapy].
    Munno G; Giannoccaro F; Muratore L; Ferrannini A
    Clin Ter; 1985 May; 113(3):235-8. PubMed ID: 2861936
    [No Abstract]   [Full Text] [Related]  

  • 40. [The efficacy of cetirizine in the treatment of perennial allergic rhinitis].
    Pacor ML; Biasi D; Carletto A; Corrocher R
    Recenti Prog Med; 1999 Jun; 90(6):325-6. PubMed ID: 10399471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.